Detalhe da pesquisa
1.
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry.
J Eur Acad Dermatol Venereol
; 37(2): 365-381, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36169355
2.
Examining the safety of relaxed drug monitoring for methotrexate in response to the COVID-19 pandemic.
Rheumatol Adv Pract
; 6(3): rkac100, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36560934